Cargando…

Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations

Cardiac magnetic resonance myocardial perfusion imaging can detect coronary artery disease and is an alternative to single-photon emission computed tomography or positron emission tomography. However, the complex, non-linear MR signal and the lack of robust quantification of myocardial blood flow ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Daviller, Clément, Boutelier, Timothé, Giri, Shivraman, Ratiney, Hélène, Jolly, Marie-Pierre, Vallée, Jean-Paul, Croisille, Pierre, Viallon, Magalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072361/
https://www.ncbi.nlm.nih.gov/pubmed/33912066
http://dx.doi.org/10.3389/fphys.2021.483714
_version_ 1783683903325732864
author Daviller, Clément
Boutelier, Timothé
Giri, Shivraman
Ratiney, Hélène
Jolly, Marie-Pierre
Vallée, Jean-Paul
Croisille, Pierre
Viallon, Magalie
author_facet Daviller, Clément
Boutelier, Timothé
Giri, Shivraman
Ratiney, Hélène
Jolly, Marie-Pierre
Vallée, Jean-Paul
Croisille, Pierre
Viallon, Magalie
author_sort Daviller, Clément
collection PubMed
description Cardiac magnetic resonance myocardial perfusion imaging can detect coronary artery disease and is an alternative to single-photon emission computed tomography or positron emission tomography. However, the complex, non-linear MR signal and the lack of robust quantification of myocardial blood flow have hindered its widespread clinical application thus far. Recently, a new Bayesian approach was developed for brain imaging and evaluation of perfusion indexes (Kudo et al., 2014). In addition to providing accurate perfusion measurements, this probabilistic approach appears more robust than previous approaches, particularly due to its insensitivity to bolus arrival delays. We assessed the performance of this approach against a well-known and commonly deployed model-independent method based on the Fermi function for cardiac magnetic resonance myocardial perfusion imaging. The methods were first evaluated for accuracy and precision using a digital phantom to test them against the ground truth; next, they were applied in a group of coronary artery disease patients. The Bayesian method can be considered an appropriate model-independent method with which to estimate myocardial blood flow and delays. The digital phantom comprised a set of synthetic time-concentration curve combinations generated with a 2-compartment exchange model and a realistic combination of perfusion indexes, arterial input dynamics, noise and delays collected from the clinical dataset. The myocardial blood flow values estimated with the two methods showed an excellent correlation coefficient (r(2) > 0.9) under all noise and delay conditions. The Bayesian approach showed excellent robustness to bolus arrival delays, with a similar performance to Fermi modeling when delays were considered. Delays were better estimated with the Bayesian approach than with Fermi modeling. An in vivo analysis of coronary artery disease patients revealed that the Bayesian approach had an excellent ability to distinguish between abnormal and normal myocardium. The Bayesian approach was able to discriminate not only flows but also delays with increased sensitivity by offering a clearly enlarged range of distribution for the physiologic parameters.
format Online
Article
Text
id pubmed-8072361
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80723612021-04-27 Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations Daviller, Clément Boutelier, Timothé Giri, Shivraman Ratiney, Hélène Jolly, Marie-Pierre Vallée, Jean-Paul Croisille, Pierre Viallon, Magalie Front Physiol Physiology Cardiac magnetic resonance myocardial perfusion imaging can detect coronary artery disease and is an alternative to single-photon emission computed tomography or positron emission tomography. However, the complex, non-linear MR signal and the lack of robust quantification of myocardial blood flow have hindered its widespread clinical application thus far. Recently, a new Bayesian approach was developed for brain imaging and evaluation of perfusion indexes (Kudo et al., 2014). In addition to providing accurate perfusion measurements, this probabilistic approach appears more robust than previous approaches, particularly due to its insensitivity to bolus arrival delays. We assessed the performance of this approach against a well-known and commonly deployed model-independent method based on the Fermi function for cardiac magnetic resonance myocardial perfusion imaging. The methods were first evaluated for accuracy and precision using a digital phantom to test them against the ground truth; next, they were applied in a group of coronary artery disease patients. The Bayesian method can be considered an appropriate model-independent method with which to estimate myocardial blood flow and delays. The digital phantom comprised a set of synthetic time-concentration curve combinations generated with a 2-compartment exchange model and a realistic combination of perfusion indexes, arterial input dynamics, noise and delays collected from the clinical dataset. The myocardial blood flow values estimated with the two methods showed an excellent correlation coefficient (r(2) > 0.9) under all noise and delay conditions. The Bayesian approach showed excellent robustness to bolus arrival delays, with a similar performance to Fermi modeling when delays were considered. Delays were better estimated with the Bayesian approach than with Fermi modeling. An in vivo analysis of coronary artery disease patients revealed that the Bayesian approach had an excellent ability to distinguish between abnormal and normal myocardium. The Bayesian approach was able to discriminate not only flows but also delays with increased sensitivity by offering a clearly enlarged range of distribution for the physiologic parameters. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8072361/ /pubmed/33912066 http://dx.doi.org/10.3389/fphys.2021.483714 Text en Copyright © 2021 Daviller, Boutelier, Giri, Ratiney, Jolly, Vallée, Croisille and Viallon. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Daviller, Clément
Boutelier, Timothé
Giri, Shivraman
Ratiney, Hélène
Jolly, Marie-Pierre
Vallée, Jean-Paul
Croisille, Pierre
Viallon, Magalie
Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations
title Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations
title_full Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations
title_fullStr Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations
title_full_unstemmed Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations
title_short Direct Comparison of Bayesian and Fermi Deconvolution Approaches for Myocardial Blood Flow Quantification: In silico and Clinical Validations
title_sort direct comparison of bayesian and fermi deconvolution approaches for myocardial blood flow quantification: in silico and clinical validations
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072361/
https://www.ncbi.nlm.nih.gov/pubmed/33912066
http://dx.doi.org/10.3389/fphys.2021.483714
work_keys_str_mv AT davillerclement directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT bouteliertimothe directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT girishivraman directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT ratineyhelene directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT jollymariepierre directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT valleejeanpaul directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT croisillepierre directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations
AT viallonmagalie directcomparisonofbayesianandfermideconvolutionapproachesformyocardialbloodflowquantificationinsilicoandclinicalvalidations